NEW GOLD INC CDA's ticker is NGD and the CUSIP is 644535106. A total of 163 filers reported holding NEW GOLD INC CDA in Q4 2015. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $41,652,000 | -23.1% | 11,873,773 | -4.9% | 0.62% | -27.6% |
| Q3 2016 | $54,166,000 | -17.5% | 12,486,720 | -17.4% | 0.85% | -20.8% |
| Q2 2016 | $65,691,000 | +4.1% | 15,125,169 | -10.4% | 1.07% | +0.8% |
| Q1 2016 | $63,112,000 | +75.4% | 16,878,855 | +9.1% | 1.06% | +54.1% |
| Q4 2015 | $35,988,000 | -1.4% | 15,468,284 | -4.8% | 0.69% | -0.3% |
| Q3 2015 | $36,512,000 | +1.0% | 16,247,249 | +20.8% | 0.69% | +13.1% |
| Q2 2015 | $36,135,000 | +1.0% | 13,455,022 | +26.0% | 0.61% | +0.8% |
| Q1 2015 | $35,770,000 | -21.8% | 10,674,567 | +0.1% | 0.61% | -16.8% |
| Q4 2014 | $45,765,000 | -10.2% | 10,660,996 | +5.8% | 0.73% | -4.6% |
| Q3 2014 | $50,978,000 | -20.8% | 10,076,944 | -0.8% | 0.77% | -17.7% |
| Q2 2014 | $64,396,000 | +27.1% | 10,154,973 | -0.8% | 0.93% | +18.4% |
| Q1 2014 | $50,676,000 | +3.6% | 10,239,941 | +9.4% | 0.79% | +1.4% |
| Q4 2013 | $48,928,000 | -12.5% | 9,359,631 | -0.1% | 0.78% | -15.0% |
| Q3 2013 | $55,906,000 | +65.7% | 9,364,743 | +79.9% | 0.91% | +53.3% |
| Q2 2013 | $33,731,000 | – | 5,206,767 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARLIN SAMS CAPITAL MANAGEMENT LLC | 4,892,638 | $20,670,000 | 32.83% |
| Kopernik Global Investors, LLC | 5,986,053 | $19,037,000 | 4.00% |
| TSP Capital Management Group, LLC | 1,480,500 | $4,708,000 | 2.17% |
| INGALLS & SNYDER LLC | 8,556,510 | $27,210,000 | 1.48% |
| VAN ECK ASSOCIATES CORP | 76,891,925 | $244,516,000 | 1.34% |
| Arete Wealth Advisors, LLC | 732,993 | $2,331,000 | 1.06% |
| ASA Gold & Precious Metals Ltd | 500,000 | $1,590,000 | 0.98% |
| Donald Smith & Co. | 11,412,647 | $36,292,000 | 0.88% |
| Hexavest Inc. | 14,545,309 | $46,232,000 | 0.60% |
| EXANE DERIVATIVES | 610,529 | $1,941,081,000 | 0.42% |